Correlation of liver function with intestinal flora, vitamin deficiency and IL-17A in patients with liver cirrhosis

Mou,Haijuan; Yang,Fengying; Zhou,Jianqin; Bao,Cuixia

doi:10.3892/etm.2018.6663

Correlation of liver function with intestinal flora, vitamin deficiency and IL-17A in patients with liver cirrhosis

Authors:
- Haijuan Mou
- Fengying Yang
- Jianqin Zhou
- Cuixia Bao
View Affiliations

Affiliations: Department of Public Health, Yantai Infectious Disease Hospital, Yantai, Shandong 264001, P.R. China, Outpatient Department, Yantai Infectious Disease Hospital, Yantai, Shandong 264001, P.R. China, Medical Department, Yantai Infectious Disease Hospital, Yantai, Shandong 264001, P.R. China, Department of Laboratory, The Affiliated Yantai Yuhuangding Hospital of Qingdao, University Medical College, Yantai, Shandong 264000, P.R. China
Published online on: August 29, 2018 https://doi.org/10.3892/etm.2018.6663
Pages: 4082-4088
Copyright: © Mou et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the correlation of liver function, intestinal flora, vitamin D and interleukin-17A (IL-17A) levels in patients with liver cirrhosis. A total of 52 patients diagnosed with posthepatitic cirrhosis and admitted into Yantai Infectious Disease Hospital (Yantai, China) from January to December in 2012 (liver cirrhosis group), and 52 patients with chronic hepatitis B (hepatitis group), and 40 healthy volunteers receiving physical examination in the hospital (normal control group) were selected into the study. The liver function, hepatitis B virus (HBV) deoxyribonucleic acid (DNA) level, intestinal flora distribution, vitamin D and IL-17A levels of all patients were detected, and the correlation among them was analyzed via Pearson's analysis. The number of Enterobacteriaceae, Enterococcus, Staphylococcus aureus and Saccharomyces in hepatitis and liver cirrhosis groups was significantly greater than in the normal control group (P<0.05), but the number of Lactobacillus, Bacteroides, Bifidobacterium and Clostridium was significantly decreased (P<0.05); the serum IL-17A levels in hepatitis and liver cirrhosis were obviously higher than that in the normal control group (P<0.05), but the serum vitamin D 25(OH) D and 1,25(OH)2D levels were obviously lower than that in the normal control group (P<0.05). In patients with liver cirrhosis, Enterobacteriaceae was positively correlated with prothrombin time (PT), Enterococcus was positively correlated with alanine aminotransferase and aspartate aminotransferase (AST) levels, Bifidobacterium was negatively correlated with AST, alkline phosphatase (AKP) and HBV DNA levels, and Bacteroides was negatively correlated with AST level and PT. There was a significant negative correlation between serum IL-17A and total bilirubin in patients with liver cirrhosis, and 25(OH) D was negatively correlated with AST, AKP and HBV DNA levels. In patients with liver cirrhosis, there was significant positive correlation between Enterococcus and IL-17A, and between Lactobacillus and 25(OH)D, but other bacteria were not obviously associated with IL-17A and vitamin D. Intestinal flora imbalance, vitamin D deficiency and IL-17A imbalance play an important role in the evolution of liver cirrhosis.

View Figures

View References

1	Liu J, Wu D, Ahmed A, Li X, Ma Y, Tang L, Mo D, Ma Y and Xin Y: Comparison of the gut microbe profiles and numbers between patients with liver cirrhosis and healthy individuals. Curr Microbiol. 65:7–13. 2012. View Article : Google Scholar : PubMed/NCBI
2	Guo RY, Chen ZJ, Chen N and Chen Y: Quantitative real-time PCR analysis of intestinal regular fungal species in fecal samples from patients with chronic hepatitis B virus infection. Lab Med. 41:591–596. 2010. View Article : Google Scholar
3	Lu H, Wu Z, Xu W, Yang J, Chen Y and Li L: Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol. 61:693–703. 2011. View Article : Google Scholar : PubMed/NCBI
4	Seo YS and Shah VH: The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin Mol Hepatol. 18:337–346. 2012. View Article : Google Scholar : PubMed/NCBI
5	Cesaro C, Tiso A, Del Prete A, Cariello R, Tuccillo C, Cotticelli G, Del Vecchio Blanco C and Loguercio C: Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis. 43:431–438. 2011. View Article : Google Scholar : PubMed/NCBI
6	Rehermann B and Nascimbeni M: Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol. 5:215–229. 2005. View Article : Google Scholar : PubMed/NCBI
7	Zhang Q, Pan YF and Ping XG: The hepatitis C virus (HCV) RNA load changes in chronic hepatitis C HCV-related liver cirrhosis and HCV-related hepatocellular carcinoma groups and genotype effects on disease progression. J Med Forum. 35:349–353. 2014.
8	Abu Mouch S, Fireman Z, Jarchovsky J, Zeina AR and Assy N: Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1) - naïve patients. World J Gastroenterol. 17:5184–5190. 2011. View Article : Google Scholar : PubMed/NCBI
9	Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE and Relman DA: Diversity of the human intestinal microbial flora. Science. 308:1635–1638. 2005. View Article : Google Scholar : PubMed/NCBI
10	Grice EA and Segre JA: The human microbiome: Our second genome. Annu Rev Genomics Hum Genet. 13:151–170. 2012. View Article : Google Scholar : PubMed/NCBI
11	McKenna P, Hoffmann C, Minkah N, Aye PP, Lackner A, Liu Z, Lozupone CA, Hamady M, Knight R and Bushman FD: The macaque gut microbiome in health, lentiviral infection, and chronic enterocolitis. PLoS Pathog. 4:e202008. View Article : Google Scholar : PubMed/NCBI
12	Dethlefsen L, Huse S, Sogin ML and Relman DA: The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 6:e2802008. View Article : Google Scholar : PubMed/NCBI
13	Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP, et al: A core gut microbiome in obese and lean twins. Nature. 457:480–484. 2009. View Article : Google Scholar : PubMed/NCBI
14	Vaishnavi C: Fecal microbiota transplantation for management of Clostridium difficile infection. Indian J Gastroenterol. 33:301–307. 2014. View Article : Google Scholar : PubMed/NCBI
15	Pompei A, Cordisco L, Amaretti A, Zanoni S, Matteuzzi D and Rossi M: Folate production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol. 73:179–185. 2007. View Article : Google Scholar : PubMed/NCBI
16	Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, Tuohy KM, Gibson GR and Delzenne NM: Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 50:2374–2383. 2007. View Article : Google Scholar : PubMed/NCBI
17	Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei D, Wang Y, Zhu B and Li L: Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology. 54:562–572. 2011. View Article : Google Scholar : PubMed/NCBI
18	Lamousé-Smith ES, Tzeng A and Starnbach MN: The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice. PLoS One. 6:e276622011. View Article : Google Scholar : PubMed/NCBI
19	Kolls JK and Lindén A: Interleukin-17 family members and inflammation. Immunity. 21:467–476. 2004. View Article : Google Scholar : PubMed/NCBI
20	Zhang X, Angkasekwinai P, Dong C and Tang H: Structure and function of interleukin-17 family cytokines. Protein Cell. 2:26–40. 2011. View Article : Google Scholar : PubMed/NCBI
21	Semedo T, Almeida Santos M, Martins P, Silva Lopes MF, Figueiredo Marques JJ, Tenreiro R and Barreto Crespo MT: Comparative study using type strains and clinical and food isolates to examine hemolytic activity and occurrence of the cyl operon in enterococci. J Clin Microbiol. 41:2569–2576. 2003. View Article : Google Scholar : PubMed/NCBI
22	Zhang JY, Zhang Z, Lin F, Zou ZS, Xu RN, Jin L, Fu JL, Shi F, Shi M, Wang HF, et al: Interleukin-17-producing CD4(⁺) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology. 51:81–91. 2010. View Article : Google Scholar : PubMed/NCBI
23	Parfieniuk-Kowerda A, Jaroszewicz J and Flisiak R: Immune regulation and viral diversity as correlates of natural and treatment induced immune control in persistent hepatitis B virus (HBV) infection. Clin Exp Hepatol. 1:35–38. 2015. View Article : Google Scholar : PubMed/NCBI
24	Schuppan D and Afdhal NH: Liver cirrhosis. Lancet. 371:838–851. 2008. View Article : Google Scholar : PubMed/NCBI
25	Bouillon R, Carmeliet G, Verlinden L, van Etten E, Verstuyf A, Luderer HF, Lieben L, Mathieu C and Demay M: Vitamin D and human health: Lessons from vitamin D receptor null mice. Endocr Rev. 29:726–776. 2008. View Article : Google Scholar : PubMed/NCBI
26	Suibhne TN, Cox G, Healy M, O'Morain C and O'Sullivan M: Vitamin D deficiency in Crohn's disease: Prevalence, risk factors and supplement use in an outpatient setting. J Crohn's Colitis. 6:182–188. 2012. View Article : Google Scholar
27	Arteh J, Narra S and Nair S: Prevalence of vitamin D deficiency in chronic liver disease. Dig Dis Sci. 55:2624–2628. 2010. View Article : Google Scholar : PubMed/NCBI
28	Malham M, Jørgensen SP, Ott P, Agnholt J, Vilstrup H, Borre M and Dahlerup JF: Vitamin D deficiency in cirrhosis relates to liver dysfunction rather than aetiology. World J Gastroenterol. 17:922–925. 2011. View Article : Google Scholar : PubMed/NCBI
29	Petta S, Cammà C, Scazzone C, Tripodo C, Di Marco V, Bono A, Cabibi D, Licata G, Porcasi R, Marchesini G, et al: Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C. Hepatology. 51:1158–1167. 2010. View Article : Google Scholar : PubMed/NCBI
30	Zúñiga S, Firrincieli D, Housset C and Chignard N: Vitamin D and the vitamin D receptor in liver pathophysiology. Clin Res Hepatol Gastroenterol. 35:295–302. 2011. View Article : Google Scholar : PubMed/NCBI
31	Drocourt L, Ourlin JC, Pascussi JM, Maurel P and Vilarem MJ: Expression of CYP3A4, CYP2B6, and CYP2C9 is regulated by the vitamin D receptor pathway in primary human hepatocytes. J Biol Chem. 277:25125–25132. 2002. View Article : Google Scholar : PubMed/NCBI